M. Elizabeth Latimer, MD received her medical degree from Tufts University School of Medicine in Boston Massachusetts. She completed her residencies in Pediatrics and Neurology at Walter Reed Army Medical Center in Washington, DC, with special certification in Child Neurology. She served as chief of the Child Neurology Division at Georgetown University Hospital in Washington, DC for five years, prior to practicing at Fairfax Hospital in Virginia.
In 2000, Dr. Latimer opened her practice of Child and Adolescent Neurology in Bethesda, MD, where she provided treatment for autism, ADHD, migraines, and other neurological conditions. She’s currently practicing out of her office in Washington DC conveniently located in the heart of Georgetown. In addition to her general neurology and headache practice, Dr. Latimer specializes in caring for PANDAS patients, and cerebral palsy patients who require spasticity management.
To view Dr. Latimer’s complete resume CLICK HERE (pdf file).
Throughout her years of working in the field of Child and Adolescent Neurology, Dr. Latimer has been involved with several health and non-profit organizations. She was a founding Board Member of the Catholic Coalition for Special Education, and served on the Board between 2004 and 2009. Additionally, Dr. Latimer is currently a member of:
Dr. Latimer has also had the honor of presenting at several events for the Child Neurology Society, the American Academy of Neurology, and has appeared in national news media as an expert in Child and Adolescent Neurology topics. Recently she was invited as a speaker for NIH, Pandas Working Group, International OCD foundation, New England Pandas Association, and Pandas d’italia.
For her commitment to her patients, and excellent service, Dr. Latimer has received recognition such as being named as a Top Doctor by the Washingtonian Magazine from 1994-2012, and also received the Compassionate Doctor Award.
While the Latimer Neurology Center works with a wide variety of neurological disorders, many of the patients we receive are for PANS and PANDAS. We are proud to be able to help children with these conditions get treatment and improve their quality of life.
In addition to PANS and PANDAS, other conditions we commonly treat include:
1. October 23-24 2012: UNC Chapel Hill Grand Rounds
2. January 2015: Triologic Meeting; The role of tonsillectomy in the management of children with PANDAS/ PANS and its efficacy relative to treatment with IVIG
3. August 2015: National Institute of Mental Health, Outreach Partner Program – Bethesda, MD
4. Need to test ones chance europa casino free spins code. June 2016: Virginia State of Otolaryngology (VSO) Panel
5. June 2016: Pacific Coast Oto-ophthalmological society meeting; The role of tonsillectomy in PANDAS Syndrome
6. October 2016: PANDAS/ PANS: An update on current management and new treatment strategies
7. October 2016: NIH (Bethesda, MD)
8. May 2017: Medstar Research Symposium: Characterization of the microbiome in tonsils of patients diagnosed with PANDAS
9. June 2017: Georgetown Grand Rounds
10. June 2017: Vanderbilt Grand Rounds
11. May 2019: Richmond ENT Grand Rounds
12. October 2019: Autoimmune Encephalitis Post-Streptococcal Evaluation & Treatment – Washington, DC Tonsillectomy including microbiome and immunology in this select population
13. October 2019: PANDAS/ PANS: Advances in Diagnosis and Treatment for Post-Infectious Auto-Immune Basal Ganglia Encephalitis – Portsmouth, NH; Tonsillectomy in the management of basal ganglia encephalitis: A review of the microbiome and the outcomes in a cohort of patients
1. Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells
2. Role of tonsillectomy and adenoidectomy in parental satisfaction of treatments for PANDAS
3. Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus Immunology: A Pilot Study
4. Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells
5. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference
6. Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in anti-neuronal antibody titers parallel changes in patient symptoms
7. Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus Immunology: A Pilot Study
8. Clinical presentation of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections in research and community settings
9. Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections
10. Role of tonsillectomy and adenoidectomy in parental satisfaction of treatments for PANDAS
Call us at 202-625-4898 to schedule an appointment today. We look forward to speaking with you.